MedPath
HSA Approval

PANADOL EXTRA CAPLET

SIN09110P

PANADOL EXTRA CAPLET

PANADOL EXTRA CAPLET

September 4, 1996

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
Licence HolderGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

**DOSAGE AND ADMINISTRATION:** For oral administration only. Adults and children over 12 years:1–2 caplets every 4 to 6 hours as required. Do not exceed the stated dose and do not take more frequently than every 4 hours. Do not give to children under 12 years. Do not take more than 8 caplets in 24 hours. Do not take more than 3 days without asking your doctors. Always use the lowest effect dose to relieve your symptoms. Do not take this medicine if you are taking any other prescription or non-prescription medicines containing paracetamol to treat pain, fever, symptoms of cold and flu.

ORAL

Medical Information

**INDICATIONS:** For extra relief from stronger pain, like bad headache, backache, joint pain and toothache.

**CONTRAINDICATIONS:** Do not use if you are allergic to Paracetamol, Caffeine or any of the other ingredients in the product.

N02BE51

paracetamol, combinations excl. psycholeptics

Manufacturer Information

gsk consumer healthcare singapore pte. ltd.

GlaxoSmithKline Dungarvan Limited

Sterling Drug (Malaya) Sdn Bhd (Primary packager)

Active Ingredients

PARACETAMOL

500 mg

Acetaminophen

CAFFEINE

65.0 mg

Caffeine

Documents

Patient Information Leaflets

Panadol Extra Caplet PIL.pdf

Approved: May 5, 2020

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PANADOL EXTRA CAPLET - HSA Approval | MedPath